Mutagenesis of the transmembrane domain of the SARS coronavirus spike glycoprotein: refinement of the requirements for SARS coronavirus cell entry

Background The spike protein (S) of SARS Coronavirus (SARS-CoV) mediates entry of the virus into target cells, including receptor binding and membrane fusion. Close to or in the viral membrane, the S protein contains three distinct motifs: a juxtamembrane aromatic part, a central highly hydrophobic stretch and a cysteine rich motif. Here, we investigate the role of aromatic and hydrophobic parts of S in the entry of SARS CoV and in cell-cell fusion. This was investigated using the previously described SARS pseudotyped particles system (SARSpp) and by fluorescence-based cell-cell fusion assays. Results Mutagenesis showed that the aromatic domain was crucial for SARSpp entry into cells, with a likely role in pore enlargement. Introduction of lysine residues in the hydrophobic stretch of S also resulted in a block of entry, suggesting the borders of the actual transmembrane domain. Surprisingly, replacement of a glycine residue, situated close to the aromatic domain, with a lysine residue was tolerated, whereas the introduction of a lysine adjacent to the glycine, was not. In a model, we propose that during fusion, the lateral flexibility of the transmembrane domain plays a critical role, as do the tryptophans and the cysteines. Conclusions The aromatic domain plays a crucial role in the entry of SARS CoV into target cells. The positioning of the aromatic domain and the hydrophobic domain relative to each other is another essential characteristic of this membrane fusion process..

Medienart:

E-Artikel

Erscheinungsjahr:

2009

Erschienen:

2009

Enthalten in:

Zur Gesamtaufnahme - volume:6

Enthalten in:

Virology journal - 6(2009), 1 vom: 24. Dez.

Sprache:

Englisch

Beteiligte Personen:

Corver, Jeroen [VerfasserIn]
Broer, Rene [VerfasserIn]
van Kasteren, Puck [VerfasserIn]
Spaan, Willy [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Fusion Pore
Membrane Fusion
Severe Acute Respiratory Syndrome
Spike Protein
Tryptophan Residue

Anmerkungen:

© Corver et al; licensee BioMed Central Ltd. 2009

doi:

10.1186/1743-422X-6-230

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

SPR029239281